PET Imaging for Treatment Response in Cancer

Imaging treatment response with FDG PET and other imaging agents have been evaluated in numerous prospective and retrospective clinical studies. As a result, PET is becoming established as a biomarker for treatment response and as a marker for patient outcome prediction.